Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Tianjin Weikai In-licenses China Rights to 3D Cell Culture System from Zyoxel

publication date: Jul 10, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Tianjin Weikai obtained exclusive China rights to manufacture and distribute TissueFlex® from Zyoxel Limited of Oxford, UK. TissueFlex® is a microbioreactor for 3D perfused cell culture. Zyoxel will receive royalties for each system sold. Zyoxel and Weikai both focus on stem cell technologies. Weikai offers stem cell CRO services and products. More details....

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...